Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORD56B is a non-coding RNA belonging to the C/D box family of snoRNAs. It contains conserved sequence motifs called the C box (UGAUGA) and D box (CUGA) and directs site-specific 2'-O-methylation of substrate RNAs, primarily ribosomal RNA[1][5]. SNORD56B is encoded within an intronic region of a host gene (NOL5A), and, like other snoRNAs, is a constituent of snoRNP complexes together with proteins such as NOP56, NOP58, Snu13, and fibrillarin[3][5]. These complexes are essential for rRNA processing and assembly, localizing to the nucleolus for modification of nascent rRNAs[5]. While important for cellular homeostasis, SNORD56B itself is not identified as a direct therapeutic target, and it has not been associated with drug interactions or safety issues.
Not applicable—no approved drugs or drug candidates target SNORD56B for therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORD56B (SNORD56B).